277 related articles for article (PubMed ID: 23211262)
1. Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?
Calderón-Larrañaga A; Poblador-Plou B; González-Rubio F; Gimeno-Feliu LA; Abad-Díez JM; Prados-Torres A
Br J Gen Pract; 2012 Dec; 62(605):e821-6. PubMed ID: 23211262
[TBL] [Abstract][Full Text] [Related]
2. Adverse drug event nonrecognition in emergency departments: an exploratory study on factors related to patients and drugs.
Roulet L; Ballereau F; Hardouin JB; Chiffoleau A; Potel G; Asseray N
J Emerg Med; 2014 Jun; 46(6):857-64. PubMed ID: 24565882
[TBL] [Abstract][Full Text] [Related]
3. Adverse drug events in the outpatient setting: an 11-year national analysis.
Bourgeois FT; Shannon MW; Valim C; Mandl KD
Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):901-10. PubMed ID: 20623513
[TBL] [Abstract][Full Text] [Related]
4. How do multi-morbidity and polypharmacy affect general practice attendance and referral rates? A retrospective analysis of consultations.
O'Regan A; O'Doherty J; O'Connor R; Cullen W; Niranjan V; Glynn L; Hannigan A
PLoS One; 2022; 17(2):e0263258. PubMed ID: 35113926
[TBL] [Abstract][Full Text] [Related]
5. Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM.
Baré M; Herranz S; Jordana R; Gorgas MQ; Ortonobes S; Sevilla D; De Jaime E; Ibarra O; Martín C;
BMJ Open; 2020 Jan; 10(1):e033322. PubMed ID: 31988230
[TBL] [Abstract][Full Text] [Related]
6. Polypharmacy and adverse drug events among propensity score matched privately insured persons with and without spinal cord injury.
Hand BN; Krause JS; Simpson KN
Spinal Cord; 2018 Jun; 56(6):591-597. PubMed ID: 29362505
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project).
Prados-Torres A; Del Cura-González I; Prados-Torres D; López-Rodríguez JA; Leiva-Fernández F; Calderón-Larrañaga A; López-Verde F; Gimeno-Feliu LA; Escortell-Mayor E; Pico-Soler V; Sanz-Cuesta T; Bujalance-Zafra MJ; Morey-Montalvo M; Boxó-Cifuentes JR; Poblador-Plou B; Fernández-Arquero JM; González-Rubio F; Ramiro-González MD; Coscollar-Santaliestra C; Martín-Fernández J; Barnestein-Fonseca MP; Valderas-Martínez JM; Marengoni A; Muth C;
Implement Sci; 2017 Apr; 12(1):54. PubMed ID: 28449721
[TBL] [Abstract][Full Text] [Related]
8. Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study.
Hanlon P; Nicholl BI; Jani BD; McQueenie R; Lee D; Gallacher KI; Mair FS
BMJ Open; 2018 Jan; 8(1):e018404. PubMed ID: 29332840
[TBL] [Abstract][Full Text] [Related]
9. Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study.
Lo Giudice I; Mocciaro E; Giardina C; Barbieri MA; Cicala G; Gioffrè-Florio M; Carpinteri G; Di Grande A; Spina E; Arcoraci V; Cutroneo PM
BMC Pharmacol Toxicol; 2019 Apr; 20(1):21. PubMed ID: 31029178
[TBL] [Abstract][Full Text] [Related]
10. Probable effects of polypharmacy and equivalent doses of psychotropic drugs on prevalence of adverse drug events among psychiatric inpatients in a general hospital in Japan.
Aoyama K; Tachi T; Kubo S; Koyama A; Watanabe M; Aoyama S; Noguchi Y; Tanaka K; Yasuda M; Shibata A; Mizui T; Teramachi H
Hum Psychopharmacol; 2024 May; 39(3):e2890. PubMed ID: 38180732
[TBL] [Abstract][Full Text] [Related]
11. Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study.
Nguyen TN; Ngangue P; Haggerty J; Bouhali T; Fortin M
Fam Pract; 2019 Nov; 36(6):706-712. PubMed ID: 31104072
[TBL] [Abstract][Full Text] [Related]
12. Identification and prevalence of adverse drug events caused by potentially inappropriate medication in homebound elderly patients: a retrospective study using a nationwide survey in Japan.
Onda M; Imai H; Takada Y; Fujii S; Shono T; Nanaumi Y
BMJ Open; 2015 Aug; 5(8):e007581. PubMed ID: 26260347
[TBL] [Abstract][Full Text] [Related]
13. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population?
Green JL; Hawley JN; Rask KJ
Am J Geriatr Pharmacother; 2007 Mar; 5(1):31-9. PubMed ID: 17608245
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study.
Ayani N; Morimoto T; Sakuma M; Kikuchi T; Watanabe K; Narumoto J
J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):397-402. PubMed ID: 34108429
[TBL] [Abstract][Full Text] [Related]
15. Comparing characteristics of adverse drug events between older and younger adults presenting to a Taiwan emergency department.
Chen YC; Huang HH; Fan JS; Chen MH; Hsu TF; Yen DH; Huang MS; Wang CY; Huang CI; Lee CH
Medicine (Baltimore); 2015 Feb; 94(7):e547. PubMed ID: 25700322
[TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with adverse drug events among older adults in emergency department.
Chen YC; Fan JS; Chen MH; Hsu TF; Huang HH; Cheng KW; Yen DH; Huang CI; Chen LK; Yang CC
Eur J Intern Med; 2014 Jan; 25(1):49-55. PubMed ID: 24200546
[TBL] [Abstract][Full Text] [Related]
17. Adverse drug events in high risk older outpatients.
Hanlon JT; Schmader KE; Koronkowski MJ; Weinberger M; Landsman PB; Samsa GP; Lewis IK
J Am Geriatr Soc; 1997 Aug; 45(8):945-8. PubMed ID: 9256846
[TBL] [Abstract][Full Text] [Related]
18. Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study.
Zhao Y; Wang J; Zhu X; Zhang X; Zhang Y; Zhang W; Dong Y
BMC Geriatr; 2023 Jul; 23(1):423. PubMed ID: 37434147
[TBL] [Abstract][Full Text] [Related]
19. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
[TBL] [Abstract][Full Text] [Related]
20. Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study.
Keats MR; Cui Y; DeClercq V; Grandy SA; Sweeney E; Dummer TJB
Support Care Cancer; 2021 Feb; 29(2):713-723. PubMed ID: 32444894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
